Literature DB >> 18797354

Long-term excess mortality in 623 patients with brain arteriovenous malformations.

Aki Laakso1, Reza Dashti, Johanna Seppänen, Seppo Juvela, Kristjan Väärt, Mika Niemelä, Risto Sankila, Juha A Hernesniemi.   

Abstract

OBJECTIVE: Long-term follow-up studies in patients with brain arteriovenous malformations (AVM) have been scarce and without proper statistical estimates of mortality. We performed a retrospective survival study in 623 consecutive patients with AVMs admitted to the Department of Neurosurgery in Helsinki University Hospital between 1951 and 2005.
METHODS: Patients were followed from admission until death or the end of 2005. Patient survival was estimated using the relative survival ratio, which provides a measure of the excess mortality experienced by the patients compared with the general Finnish population matched by age, sex, and calendar time.
RESULTS: Median follow-up was 11.9 years, and total follow-up was 10,165 person-years. Treatment was conservative in 155 patients. Total AVM occlusion was attained in 356 patients, and partial occlusion was obtained in 94 patients. Overall, 206 deaths were observed. Of these, 100 were related to AVMs. Diagnosis of AVM was associated with significant long-term excess mortality, with cumulative relative survival ratios of 0.85 (95% confidence interval, 0.81-0.88) and 0.69 (95% confidence interval, 0.62-0.75) at 10 and 30 years after admission, respectively. Men had higher excess mortality than women. The excess in mortality was highest in conservatively treated patients, intermediate in patients with partially occluded AVMs, and lowest in those with totally occluded AVMs. The subgroup with the best outcome consisted of those with totally occluded unruptured AVMs, which did not demonstrate excess mortality after the first year.
CONCLUSION: AVMs are associated with long-term excess mortality that may be reduced by active, even partial, treatment. Male patients have a higher excess mortality rate than female patients.

Entities:  

Mesh:

Year:  2008        PMID: 18797354     DOI: 10.1227/01.NEU.0000320439.27895.24

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  16 in total

1.  Predictors for occlusion of cerebral AVMs following radiation therapy : Radiation dose and prior embolization, but not Spetzler-Martin grade.

Authors:  Stefan Knippen; Florian Putz; Sabine Semrau; Ulrike Lambrecht; Arzu Knippen; Michael Buchfelder; Sven Schlaffer; Tobias Struffert; Rainer Fietkau
Journal:  Strahlenther Onkol       Date:  2016-10-18       Impact factor: 3.621

2.  Acute management of brain arteriovenous malformations.

Authors:  Andreas Hartmann; J P Mohr
Journal:  Curr Treat Options Neurol       Date:  2015-05       Impact factor: 3.598

Review 3.  Molecular imaging of cerebrovascular lesions.

Authors:  Nohra Chalouhi; Pascal Jabbour; Vincent Magnotta; David Hasan
Journal:  Transl Stroke Res       Date:  2013-10-23       Impact factor: 6.829

4.  The rationale behind "A Randomized Trial of Unruptured Brain AVMs" (ARUBA).

Authors:  Christian Stapf
Journal:  Acta Neurochir Suppl       Date:  2010

Review 5.  Hemorrhage rates and risk factors in the natural history course of brain arteriovenous malformations.

Authors:  W Caleb Rutledge; Nerissa U Ko; Michael T Lawton; Helen Kim
Journal:  Transl Stroke Res       Date:  2014-06-15       Impact factor: 6.829

6.  Prognostic factors for complete obliteration of arteriovenous malformations treated with LINAC-based stereotactic radiosurgery.

Authors:  Tim J Kruser; Wolfgang A Tome; Songwon Seo; John S Kuo; Patrick A Turski; Richard J Chappell; Rufus A Scrimger; Minesh P Mehta
Journal:  J Radiosurg SBRT       Date:  2011

7.  Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.

Authors:  J P Mohr; Michael K Parides; Christian Stapf; Ellen Moquete; Claudia S Moy; Jessica R Overbey; Rustam Al-Shahi Salman; Eric Vicaut; William L Young; Emmanuel Houdart; Charlotte Cordonnier; Marco A Stefani; Andreas Hartmann; Rüdiger von Kummer; Alessandra Biondi; Joachim Berkefeld; Catharina J M Klijn; Kirsty Harkness; Richard Libman; Xavier Barreau; Alan J Moskowitz
Journal:  Lancet       Date:  2013-11-20       Impact factor: 79.321

Review 8.  Chinese Cerebrovascular Neurosurgery Society and Chinese Interventional & Hybrid Operation Society, of Chinese Stroke Association Clinical Practice Guidelines for Management of Brain Arteriovenous Malformations in Eloquent Areas.

Authors:  Mingze Wang; Yuming Jiao; Chaofan Zeng; Chaoqi Zhang; Qiheng He; Yi Yang; Wenjun Tu; Hancheng Qiu; Huaizhang Shi; Dong Zhang; Dezhi Kang; Shuo Wang; A-Li Liu; Weijian Jiang; Yong Cao; Jizong Zhao
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

9.  Hypofractionated stereotactic radiotherapy for large or involving critical organs cerebral arteriovenous malformations.

Authors:  Sławomir Blamek; Dawid Larysz; Leszek Miszczyk; Adam Idasiak; Adam Rudnik; Rafał Tarnawski
Journal:  Radiol Oncol       Date:  2013-02-01       Impact factor: 2.991

10.  Robotic radiosurgery versus micro-multileaf collimator: a dosimetric comparison for large or critically located arteriovenous malformations.

Authors:  Sławomir Blamek; Aleksandra Grządziel; Leszek Miszczyk
Journal:  Radiat Oncol       Date:  2013-08-23       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.